Linked research, clinical, and regulatory source pathways.
Company profile
About Medidata
Medidata Solutions is a leading provider of cloud-based clinical trial technology and data analytics for the life sciences industry. The company offers a comprehensive unified platform that integrates three core experiences: Study Experience (trial management, financial management, feasibility), Patient Experience (engagement, eCOA, decentralized trials, diversity programs), and Data Experience (EDC, data quality, medical coding, imaging). Medidata's platform supports the entire clinical trial lifecycle from design and planning through study execution to closeout and post-trial activities. The company serves a diverse customer base including large biopharma, emerging and mid-sized biotech companies, MedTech firms, CROs, and academic/not-for-profit research organizations. Key solutions include Rave EDC for electronic data capture, CTMS for trial management, eTMF for document management, RTSM for randomization and supply management, and innovative offerings like Synthetic Control Arm for external control arms and Health Record Connect for EHR interoperability. Medidata emphasizes AI-powered capabilities, patient-centricity, and data-driven insights to accelerate clinical development and improve trial outcomes. The platform is designed to enhance operational efficiency, ensure regulatory compliance, and support diverse therapeutic areas including oncology, vaccines, and CNS disorders.
Company description Medidata official website
Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Work at Medidata?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- CNS
- Oncology
- Vaccines
Who it serves
- Academic & Not-for-profit
- CROs
- Emerging & Mid-sized Biopharma
- Large Biopharma
- MedTech
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: Cerner, EHR-to-EDC, Epic, Healthcare data interoperability systems.
Geographic context
MarketsGlobal
Company sourceOfficial website
Company milestones
Platform expansion
2nd annual State of AI in Clinical Trials report published, Patient Insights Program launched, Site Insights Program established
Partnerships
Recorded partners
- CRO Partners
- Industry Partnerships
- Medidata Research Alliance
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Progression-free survival and overall survival in the first-line treatment of BRCA wild-type advanced epithelial ovarian cancer: An analysis of patient-level data pooled from historical clinical trials.Cancer · Oct 1, 2026
Cost-Effectiveness of Endovascular vs Open Surgery for Chronic Limb-Threatening Ischemia.JAMA network open · Aug 3, 2026
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.Leukemia · Jul 17, 2026
3- versus 6-min walk test in pulmonary arterial hypertension.ERJ open research · Jul 1, 2026
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.Nature medicine · Apr 1, 2026
Accessible data collection methods in clinical trials: do current best practices for the implementation of electronic patient-reported outcome measures (ePROMs) meet accessibility standards?Journal of patient-reported outcomes · Mar 25, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
50% reduction in study build times
Quanticate case study
50% slashed from go-live times
Global CRO case study
50% increase in site count
Mid-sized sponsor rare disease trial
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Medidata
Recent articles published on Medidata's official website.
Our Story with ME/CFS: A Conversation Between Mum and DaughterBy Tina and Lottie Mincher
Read on MedidataThe Invisible Erosion: Identifying the Silent Quality Killers of Clinical Trial SuccessPart 1 of a 3-part series
Read on MedidataMan Up to Cancer’s Trevor Maxwell on Community and Advocacy
Read on MedidataEvaluating Cardiac Effort: How Medidata Modernized the 6-Minute Walk Test
Read on MedidataWe Will All Be Patients Someday: Why Medidata’s Study Experience is a Human PromiseBy Tina Mincher
Read on Medidata07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
When Perfect AI Scores Don't Translate to Better Patient Care: The Benchmark Illusion Unraveling Clinical AI
A landmark trial reveals that AI tools can ace every technical metric while delivering no measurable improvement in patient outcomes—forcing regulators and sponsors to rethink how clinical algorithms are validated.
Clinical AI · Sep 9, 2026
Clinical Trial AI Delivers 82-Fold Return in Tufts Economic Model, But Humans Still Hold the Reins
New analysis quantifies up to $21 million in value from Medable's monitoring agent for phase 3 oncology trials, establishing the first major ROI benchmark as the industry moves from pilot programs to production deployment.
Drug Discovery & Research · Aug 27, 2026
How a $2 Billion Acquisition Could End the Era of Fragmented Drug Safety Data
Dassault Systèmes' purchase of ArisGlobal aims to connect siloed healthcare systems and detect emerging drug risks before they reach patients.
Healthcare Operations · Aug 2, 2026
Clinical Trial AI Gets a Major Overhaul as Medidata Bets on Platform Integration Over Point Solutions
New embedded AI layer aims to solve biopharma's fragmented tooling problem as industry leaders admit 71% of current AI deployments fall short of expectations.
Drug Discovery & Research · Jul 25, 2026
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.